What You Should Know:
– CaringAI, a healthcare AI company focused on advancing how dementia is detected and managed, announced its official launch alongside the appointment of Dr. Stephanie Ruth Young, M.Ed., Ph.D., as Clinical Research Advisor.
– CaringAI’s first product, a phone-optimized cognitive screening and care planning platform, uses speech-based AI to overcome barriers for clinicians, caregivers, and millions of older adults at risk for cognitive decline.
– Dr. Young’s deep clinical and research expertise will provide critical oversight and guidance to ensure the technology meets both scientific and practical care thresholds as CaringAI launches.
CaringAI’s Product Suite: Speech-Based AI for Comprehensive Support
Co-Founded with FutureSight Ventures, CaringAI brings together leaders in clinical research, dementia care, and artificial intelligence. Its product suite is designed to support early detection, care coordination, and real-time decision-making:
- CaringAI Listen™: A phone-first, multimodal voice agent that delivers structured cognitive assessments and passively analyzes speech to generate DSM-5–aligned cognitive reports and care recommendations.
- CaringAI Plan™: A care planning assistant powered by dementia-specific research and navigation guidelines, enabling care teams to build customized, evidence-based plans based on screening results or existing patient needs.
Bridging Gaps in Dementia Detection and Care Planning
Dr. Stephanie Ruth Young is a licensed psychologist and Assistant Professor at Northwestern University Feinberg School of Medicine, specializing in cognitive aging, neuropsychological assessment, and technology implementation in clinical care. As Principal and Co-Investigator on several NIH-funded grants, including the MyCog and MyCog Mobile projects, she has led efforts to embed innovative cognitive screening tools into real-world clinical workflows, directly supporting CaringAI’s mission.
“Dr. Young brings a rare combination of clinical, academic, and implementation experience that will help ensure our tools are not only evidence-based, but practical for real-world care,” said Justin Mason, CEO of CaringAI. “Her leadership in cognitive aging research and her work integrating technology into frontline settings directly supports our mission to make dementia detection more accessible, scalable, and aligned with the needs of older adults, caregivers, and clinical teams.”
